46 Woodstock Road,
Oxford, OX2 6HT
Partner, Life Sciences
Claire has more than 20 years of experience across the biopharmaceutical industry in the UK and US, including R&D strategy, licensing, business development and corporate investment. She leads company creation and portfolio strategy in Life Sciences, working closely with founders and academics to build high-potential ventures and support their long-term growth.
Claire’s previous roles span UCB, Sanofi-Genzyme and AstraZeneca. Prior to joining OSE in 2020, she was Head of Investment at Pioneer Group, focused on early-stage venture creation. She’s also supported many UK accelerators and served as an assessor for Innovate UK.
Claire holds a BSc in Physiology, a PhD in Physiology and an MBA in Entrepreneurship.

Oxford researchers & innovators
We partner with researchers and innovators across Oxford, Harwell and Culham to explore commercial potential, co-create ventures and build companies.

Investors
We’ve raised over £850m from global investors keen to access Oxford’s diverse, world-leading science. Our shareholders don’t just back OSE – many also co-invest alongside us.

Co-investors
We partner with specialist global investors to fund and scale our companies – from pre-seed to growth. Together, OSE and our co-investors have invested more than £3bn.